Agilent Technologies, Inc. (A)
USD 121.03
(-0.71%)
USD 121.03
(-0.71%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.35 Billion USD | -16.56% |
| 2022 | 1.61 Billion USD | 20.12% |
| 2021 | 1.34 Billion USD | 59.22% |
| 2020 | 846 Million USD | -10.1% |
| 2019 | 941 Million USD | 1.4% |
| 2018 | 928 Million USD | 10.34% |
| 2017 | 841 Million USD | 36.75% |
| 2016 | 615 Million USD | 17.82% |
| 2015 | 522 Million USD | -37.18% |
| 2014 | 831 Million USD | -12.62% |
| 2013 | 951 Million USD | -15.01% |
| 2012 | 1.11 Billion USD | 4.48% |
| 2011 | 1.07 Billion USD | 89.22% |
| 2010 | 566 Million USD | 1104.26% |
| 2009 | 47 Million USD | -94.09% |
| 2008 | 795 Million USD | 36.13% |
| 2007 | 584 Million USD | 25.86% |
| 2006 | 464 Million USD | 156.35% |
| 2005 | 181 Million USD | -53.11% |
| 2004 | 386 Million USD | 153.24% |
| 2003 | -725 Million USD | 54.88% |
| 2002 | -1.6 Billion USD | -106.56% |
| 2001 | -778 Million USD | -173.88% |
| 2000 | 1.05 Billion USD | 42.11% |
| 1999 | 741 Million USD | 67.65% |
| 1998 | 442 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 363 Million USD | -9.25% |
| 2024 Q1 | 400 Million USD | -1.96% |
| 2024 Q3 | 333 Million USD | -8.26% |
| 2023 Q1 | 426 Million USD | -9.55% |
| 2023 FY | 1.35 Billion USD | -16.56% |
| 2023 Q4 | 408 Million USD | 206.77% |
| 2023 Q3 | 133 Million USD | -65.27% |
| 2023 Q2 | 383 Million USD | -10.09% |
| 2022 Q3 | 411 Million USD | 14.17% |
| 2022 FY | 1.61 Billion USD | 20.12% |
| 2022 Q2 | 360 Million USD | -4.26% |
| 2022 Q1 | 376 Million USD | -4.81% |
| 2022 Q4 | 471 Million USD | 14.6% |
| 2021 Q1 | 328 Million USD | 9.7% |
| 2021 Q4 | 395 Million USD | 17.56% |
| 2021 Q3 | 336 Million USD | 16.67% |
| 2021 FY | 1.34 Billion USD | 59.22% |
| 2021 Q2 | 288 Million USD | -12.2% |
| 2020 Q4 | 299 Million USD | 30.0% |
| 2020 FY | 846 Million USD | -10.1% |
| 2020 Q2 | 102 Million USD | -52.56% |
| 2020 Q1 | 215 Million USD | -14.0% |
| 2020 Q3 | 230 Million USD | 125.49% |
| 2019 FY | 941 Million USD | 1.4% |
| 2019 Q1 | 250 Million USD | 0.4% |
| 2019 Q2 | 216 Million USD | -13.6% |
| 2019 Q3 | 225 Million USD | 4.17% |
| 2019 Q4 | 250 Million USD | 11.11% |
| 2018 Q4 | 249 Million USD | 10.67% |
| 2018 Q3 | 225 Million USD | 4.65% |
| 2018 Q2 | 215 Million USD | -10.04% |
| 2018 Q1 | 239 Million USD | 2.58% |
| 2018 FY | 928 Million USD | 10.34% |
| 2017 Q2 | 201 Million USD | -2.43% |
| 2017 FY | 841 Million USD | 36.75% |
| 2017 Q4 | 233 Million USD | 15.92% |
| 2017 Q3 | 201 Million USD | 0.0% |
| 2017 Q1 | 206 Million USD | 12.57% |
| 2016 Q2 | 131 Million USD | -15.48% |
| 2016 FY | 615 Million USD | 17.82% |
| 2016 Q4 | 183 Million USD | 25.34% |
| 2016 Q3 | 146 Million USD | 11.45% |
| 2016 Q1 | 155 Million USD | -0.64% |
| 2015 Q4 | 156 Million USD | 8.33% |
| 2015 Q2 | 107 Million USD | -6.96% |
| 2015 FY | 522 Million USD | -37.18% |
| 2015 Q3 | 144 Million USD | 34.58% |
| 2015 Q1 | 115 Million USD | -33.91% |
| 2014 Q1 | 218 Million USD | -23.51% |
| 2014 FY | 831 Million USD | -12.62% |
| 2014 Q2 | 210 Million USD | -3.67% |
| 2014 Q3 | 229 Million USD | 9.05% |
| 2014 Q4 | 174 Million USD | -24.02% |
| 2013 FY | 951 Million USD | -15.01% |
| 2013 Q4 | 285 Million USD | 20.76% |
| 2013 Q3 | 236 Million USD | 10.8% |
| 2013 Q2 | 213 Million USD | -1.84% |
| 2013 Q1 | 217 Million USD | -21.94% |
| 2012 Q3 | 270 Million USD | -10.0% |
| 2012 Q2 | 300 Million USD | 10.7% |
| 2012 Q1 | 271 Million USD | -13.42% |
| 2012 FY | 1.11 Billion USD | 4.48% |
| 2012 Q4 | 278 Million USD | 2.96% |
| 2011 Q4 | 313 Million USD | 11.39% |
| 2011 FY | 1.07 Billion USD | 89.22% |
| 2011 Q1 | 211 Million USD | 3.94% |
| 2011 Q2 | 266 Million USD | 26.07% |
| 2011 Q3 | 281 Million USD | 5.64% |
| 2010 Q3 | 115 Million USD | -25.32% |
| 2010 Q1 | 94 Million USD | 32.39% |
| 2010 FY | 566 Million USD | 1104.26% |
| 2010 Q4 | 203 Million USD | 76.52% |
| 2010 Q2 | 154 Million USD | 63.83% |
| 2009 Q3 | -1 Million USD | 97.87% |
| 2009 Q4 | 71 Million USD | 7200.0% |
| 2009 FY | 47 Million USD | -94.09% |
| 2009 Q1 | 24 Million USD | -90.48% |
| 2009 Q2 | -47 Million USD | -295.83% |
| 2008 FY | 795 Million USD | 36.13% |
| 2008 Q1 | 134 Million USD | -29.47% |
| 2008 Q4 | 252 Million USD | 15.6% |
| 2008 Q3 | 218 Million USD | 14.14% |
| 2008 Q2 | 191 Million USD | 42.54% |
| 2007 FY | 584 Million USD | 25.86% |
| 2007 Q2 | 131 Million USD | 37.89% |
| 2007 Q1 | 95 Million USD | -5.0% |
| 2007 Q3 | 168 Million USD | 28.24% |
| 2007 Q4 | 190 Million USD | 13.1% |
| 2006 Q3 | 207 Million USD | 84.82% |
| 2006 Q4 | 100 Million USD | -51.69% |
| 2006 Q2 | 112 Million USD | 148.89% |
| 2006 Q1 | 45 Million USD | 152.94% |
| 2006 FY | 464 Million USD | 156.35% |
| 2005 Q4 | -85 Million USD | -195.51% |
| 2005 Q1 | 95 Million USD | 6.74% |
| 2005 Q3 | 89 Million USD | 8.54% |
| 2005 Q2 | 82 Million USD | -13.68% |
| 2005 FY | 181 Million USD | -53.11% |
| 2004 FY | 386 Million USD | 153.24% |
| 2004 Q1 | 79 Million USD | 41.07% |
| 2004 Q2 | 111 Million USD | 40.51% |
| 2004 Q3 | 107 Million USD | -3.6% |
| 2004 Q4 | 89 Million USD | -16.82% |
| 2003 Q3 | -190 Million USD | 43.28% |
| 2003 Q1 | -256 Million USD | 33.85% |
| 2003 FY | -725 Million USD | 54.88% |
| 2003 Q2 | -335 Million USD | -30.86% |
| 2003 Q4 | 56 Million USD | 129.47% |
| 2002 Q2 | -349 Million USD | 21.04% |
| 2002 FY | -1.6 Billion USD | -106.56% |
| 2002 Q4 | -387 Million USD | 9.79% |
| 2002 Q3 | -429 Million USD | -22.92% |
| 2002 Q1 | -442 Million USD | 32.83% |
| 2001 FY | -778 Million USD | -173.88% |
| 2001 Q4 | -658 Million USD | -92.4% |
| 2001 Q3 | -342 Million USD | -451.61% |
| 2001 Q2 | -62 Million USD | -122.22% |
| 2001 Q1 | 279 Million USD | -39.08% |
| 2000 Q3 | 210 Million USD | -1.87% |
| 2000 Q2 | 214 Million USD | 25.15% |
| 2000 Q1 | 171 Million USD | 103.33% |
| 2000 Q4 | 458 Million USD | 118.1% |
| 2000 FY | 1.05 Billion USD | 42.11% |
| 1999 Q4 | -5.14 Billion USD | -346.38% |
| 1999 FY | 741 Million USD | 67.65% |
| 1999 Q3 | 2.08 Billion USD | 3.83% |
| 1999 Q2 | 2.01 Billion USD | 12.54% |
| 1999 Q1 | 1.78 Billion USD | 0.0% |
| 1998 FY | 442 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Charles River Laboratories International, Inc. | 617.26 Million USD | -118.708% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | -6.973% |
| Danaher Corporation | 5.2 Billion USD | 74.048% |
| Enzo Biochem, Inc. | -9.81 Million USD | 13851.655% |
| IQVIA Holdings Inc. | 1.97 Billion USD | 31.715% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -86.053% |
| Mettler-Toledo International Inc. | 1.15 Billion USD | -17.198% |
| Qiagen N.V. | 445.24 Million USD | -203.202% |
| Revvity, Inc. | 300.56 Million USD | -349.159% |
| Thermo Fisher Scientific Inc. | 6.85 Billion USD | 80.318% |
| Waters Corporation | 817.67 Million USD | -65.102% |